CAS: 103628-46-2; 1-(3-(2-(Dimethylamino)Ethyl)-1H-Indol-5-yl)-N-Methylmethanesulfonamide

该化合物是选择性的血清素受体激动剂,主要针对5-HT1Band 5-HT1D次型,用于急性治疗偏头痛和集束头痛.其机制包括抑制脊髓血管血管,抑制食炎性...

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号19718-92-4 4-(二甲氨基)丁醛缩二甲醇 | CAS号139272-29-0 4-肼基-N-甲基苯甲磺酰胺 | CAS号795298-24-7 1-(3-(2-(dimeth... | CAS号648909-52-8 3-(2-dimethylam... | CAS号61-54-1 色胺 | CAS号50-00-0 甲醛 | CAS号88919-22-6 3-(2-氨基乙基)-N-甲基... | CAS号103628-60-0 3-(2-dimethylam... | CAS号153654-26-3 2-carboxy-3-[2-... | CAS号212069-94-8 舒马普坦N-氧化物 | CAS号103628-48-4 琥珀酸舒马普坦

合成工艺路线路线简述

    Oxalate Salt Of 3-[2-(Dimethylamino)Ethyl]-N-Ethoxycarbonyl-N-Methyl-1H-Indole-5-Methanesulphonamide置于甲醇,氢氧化钾体系中,用 水 用作溶剂,化学反应 5.0H,以95%的收率获得磺马曲坦
    参考文献:Synthesis Of 5-Substituted Indole Derivatives,I. An Improved Method For The Synthesis Of Sumatriptan
    标题:Synthesis Of 5-Substituted Indole Derivatives,I. An Improved Method For The Synthesis Of Sumatriptan
    摘要:An Improved Synthesis Of Sumatriptan (Ib) Via Fischer Cyclization Was Achieved By Introducing The Ethoxycarbonyl Group On The N-Atom Of The Sulphonamide Moiety In N-Methyl-4-Hydrazinobenzenemethanesulphonamide (7). As A Result,Substitution On The Benzylic Carbon Of The Indole Nucleus Could Be Avoided; However,Formation Of 1,1-Bis-(Indol-2-yl)-4-Dimethylaminobutane-Type By-Product (19) Was Observed. The Indolization Procedure Was Optimized To Suppress The Unwanted Side Reaction. The N-Protection Of The Sulphonamide Moiety Was Found To Be Beneficial Regarding The Purification Of The 3-[2-(Dimethylamino)Ethyl]-N-Ethoxycarbonyl-N-Methyl-1H-Indole-5-Methanesulphonamide (18).
    Doi:10.3987/com-97-8087

    专利信息


    专利号:US-8822702-B2
    优先权日:2002-12-20
    标 题 :Synthesis of amines and intermediates for the synthesis thereof
    发明人:BERENS ULRICH; DOSENBACH OLIVER; SPRENGER DANIEL
    权利人:BERENS ULRICH; DOSENBACH OLIVER; SPRENGER DANIEL; BASF SE
    摘要:The invention relates in a first embodiment to a method for the manufacture of esters of the formula I, n nor especially of amides of the formula II,n n nwherein the symbols have the meanings given in the specification, as well as other intermediates and compounds useful in the synthesis of tryptamines and other substances mentioned in the title. The synthesis methods and intermediates are useful in the synthesis of pharmaceuticals.

    专利号:US-8889897-B2
    优先权日:2011-12-23
    标 题:Electrocarboxylation synthesis for obtaining intermediates useful for the synthesis of SPAN derivatives
    发明人:OSSO J ORIOL; VEGA LOURDES F; GALLARDO ILLUMINADO; GUIRADO GONZALO; GOMEZ ANA BELEN; RECHE FRANCISCA IRENE
    权利人:AIR PROD & CHEM
    摘要:The present invention relates to a process for obtaining a compound of formula (1), (2) or (3) by means of a electrocarboxylation with CO 2 . The present invention also relates to the new intermediates (1) and (2). The present invention further relates to the use of intermediates (1) and (2) as starting materials for the synthesis of SPAN derivatives.

    专利号:US-2025188502-A1
    优先权日:2022-03-10
    标 题 :Biocatalyst and method for the synthesis of ubrogepant intermediates
    发明人:CHEN HAIBIN; HU HU; CAI BAOQIN; XU JUNPENG; LIU SITONG; JIN LUPING; WU XINWEI; CUI QINYAN; ZHANG CHENGXIAO; ZHU KAILONG
    权利人:ENZYMASTER NINGBO BIO ENG CO LTD
    摘要:This application provides engineered transaminase polypeptides for the synthesis of Ubrogepant intermediates with high stereoselectivity, high catalytic activity and good stability. This application also provides a reaction process for the asymmetric synthesis of Ubrogepant intermediates using the transaminase polypeptide.

    专利号:US-8697876-B2
    优先权日:2010-04-02
    标 题:Compositions and methods of synthesis of pyridinolypiperidine 5-HT1F agonists
    发明人:CARNIAUX JEAN-FRANCOIS; CUMMINS JONATHAN
    权利人:CARNIAUX JEAN-FRANCOIS; CUMMINS JONATHAN; COLUCID PHARMACEUTICALS INC
    摘要:The present invention provides a novel polymorph of the hemisuccinate salt of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide (Form A) characterized by a unique X-ray diffraction pattern and Differential Scanning Calorimetry profile, as well as a unique crystalline structure. This polymorph is useful in pharmaceutical compositions, for example, for the treatment and prevention of migraine. The invention also provides a process for the synthesis of pyridinoylpiperidine compounds of Formula I in high yield and high purity. In particular, the provides a process for the preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide, its hemisuccinate salt and polymorph (Form A).

    专利号:US-7786156-B2
    优先权日:2004-01-28
    标 题 :Synthesis methods and intermediates for the manufacture of Rizatriptan
    发明人:MARTIN PIERRE; BERENS ULRICH; BOUDIER ANDREAS; DOSENBACH OLIVER
    权利人:RATIOPHARM GMBH
    摘要:The invention relates to a process for the manufacture of an 1,2,4-triazol-1-yl compound of the formula [A], n nor a salt thereof, wherein each of R3 and R4 is hydrogen or lower alkyl, said process comprising reacting a hydrazine compound of the formula [B]n n nwherein R is hydrogen or acyl, R2 is hydrogen or a protecting group, are hydrogen or lower alkyl, and R6 is hydrogen or COOR7, or a salt thereof, with a 1,2,4-triazolyl forming reagent.n n In addition, novel intermediates for the synthesis of the anti-migraine agent Rizatriptan and methods for their synthesis are presented.

    专利号:US-2024082118-A1
    优先权日:2021-05-19
    标 题:Topical compositions and methods of preparing the same
    发明人:ABRAMOVICH SAGI; AVIDOR GAL; LANDA BENZION
    权利人:LANDA LABS 2012 LTD
    摘要:There is disclosed a composition comprising a water-insoluble thermoplastic compound capable of stimulating collagen synthesis (CSSC), the CSSC having a molecular weight of more than 0.6 kDa and being dispersed in a polar carrier as nano-elements having an average diameter of 200 nm or less and a viscosity of 107 mPa·s or less. The nano-elements of CSSC can be capable of stimulating the synthesis of skin proteins and/or enabling the delivery of active agents upon their application to a surface to be treated therewith. Methods for preparing the compositions and uses thereof are also provided.
    江苏省金坛市兢业医化技术研究所
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jy-chem.com
    电话: 0519-82765788 82765761👤
    📞江苏省金坛市兢业医化技术研究所 ⚠️参考联系方式

    销售电话:0519-82765788 82765761
    邮箱:yeyin@depeichem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    广州合诚实业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.honsea.com
    电话: 020-38870989👤
    📞广州合诚实业有限公司 ⚠️参考联系方式

    销售电话:020-38870989
    邮箱:gzhs999@163.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:黄埔区萝岗区云埔工业区云城路8号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖南九典制药股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hnjiudian.com
    电话: 0731-88220220👤
    📞湖南九典制药股份有限公司 ⚠️参考联系方式

    销售电话:0731-88220220
    邮箱:yly@jiudianph.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    杭州福莱蒽特股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.flariant.com
    企业联系电话:0571-22819002 22819001 22819000👤
    📞杭州福莱蒽特股份有限公司 ⚠️参考联系方式

    电话:0571-22819002 22819001 22819000

    传真:0571-22819008
    邮箱:jane@flariant.com
    通信地址: 杭州萧山金城路1068号水务大厦B座8楼
    邮编: 311203
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:杭州萧山金城路1068号水务大厦B座8楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Tajti J, Csáti A, Szok D. Szumatriptán–naproxén-nátrium fix dózisú kombinációja a migrén akut kezelésében – irodalmi áttekintés [Sumatriptan- naproxen sodium fix-dose combination for acute migraine treatment, a review]. Ideggyogy Sz. 2023 Sep 30;76(9-10):293-296. Hungarian. doi: 10.18071/isz.76.0293.
    142:68-75. doi: 10.1016/j.pediatrneurol.2023.01.016. Epub 2023 Feb 4. 12(4):102-116. doi: 10.4103/jwas.jwas_183_22. Epub 2022 Nov 23.
    4: Assadpour S, Shiran MR, Asadi P, Akhtari J, Sahebkar A. Harnessing Intranasal Delivery Systems of Sumatriptan for the Treatment of Migraine. Biomed Res Int. 2022 Jan 15;2022:3692065. doi: 10.1155/2022/3692065.

    合成参考文献


    参考文献:10.2165/11590370-000000000-00000
    摘要:Källén B, Nilsson E, Otterblad Olausson P. Delivery outcome after maternal use of drugs for migraine: a register study in Sweden. Drug Saf. 2011 Aug 01;34(8):691–703. doi: 10.2165/11590370-000000000-00000.
    参考文献:10.1107/s1600536811015959
    摘要:Temel E, Demircan A, Arslan H, Büyükgüngör O. (3aR,6S,7aR)-7a-Bromo-2-methylsulfonyl-1,2,3,6,7,7a-hexahydro-3a,6-epoxyisoindole. Acta Crystallogr E Struct Rep Online. 2011 May 07;67(6):o1304–5. doi: 10.1107/s1600536811015959.
    摘要:Adams SM, Standridge JB. Practical strategy for detecting and relieving cluster headaches. J Fam Pract. 2005 Dec;54(12):1035–40.
    参考文献:10.1007/s00404-011-1964-0
    摘要:Wittmann M, Dewald D, Urbach H, Gast A, Linnebank M, Baumgarten G, Knuefermann P, Hering R. Sinus venous thrombosis: a differential diagnosis of postpartum headache. Archives of Gynecology and Obstetrics. 2011 Jul 20;285(1):93–7. doi: 10.1007/s00404-011-1964-0.
    参考文献:10.3109/00207454.2011.605191
    摘要:Díaz-Insa S, Goadsby PJ, Zanchin G, Fortea J, Falqués M, Vila C. The Impact of Allodynia on the Efficacy of Almotriptan When Given Early in Migraine: Data From the “Act When Mild” Study. International Journal of Neuroscience. 2011 Aug 22;121(12):655–61. doi: 10.3109/00207454.2011.605191.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知